Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Tables)

v3.24.1
Revenue from Contracts with Customers (Tables)
3 Months Ended
Dec. 31, 2023
Revenue from Contracts with Customers [Abstract]  
Revenue from Customers by Products

Three Months Ended

December 31,

2023

2022

FC2

Global public health sector

$

1,507,007

$

2,336,997

U.S. prescription channel

633,719

163,004

Total FC2

2,140,726

2,500,001

ENTADFI

7,793

Net revenues

$

2,140,726

$

2,507,794

Revenue by Geographic Area

Three Months Ended

December 31,

2023

2022

United States

$

1,356,089

$

809,377

Uganda

*

257,469

Other

784,637

1,440,948

Net revenues

$

2,140,726

$

2,507,794

*Less than 10% of total net revenues